Total Pageviews

Saturday, 4 May 2013

Bombers chairman David Evans rejects accusations that players are gaining any advantage this season

Research carried out in the last few years has shown that if you were to take the controversial supplements (peptides) you are likely to suffer from soft tissue injures while playing. Bombers had the highest rate of soft tissue injures in the league last year.

Bombers chairman David Evans says his club will prove it is not gaining any advantage this season from the controversial supplement program carried out last year.

AFL chief executive Andrew Demetriou spoke about rival clubs saying bombers having an unfair advantage because of they unbeaten start to they season. 


Evans repeated on Friday that he would not publicly detail the practices that took place at the club last season while the AFL and Australian Sports Anti-Doping Authority (ASADA) investigation into whether they breached anti-doping rules continues.


"I would like to thank Andrew Demetriou for his support of the club yesterday when he warned other clubs against what he called scurrilous innuendo that our players have some kind of advantage," Evans said at a Bombers' pre-match function.


"I can also promise you this: whatever happened last year with what I conceded were irregular practices, there is no advantage to our players and this will be proven."


Evans said it was tough having the club being the subject of constant speculation without being able to publicly fight back, given the Bombers don't want to compromise the investigation.


"I would love nothing more than to be correcting some of the more wild accusations and speculation that's occurred over the time," he said.


"But I ask you again for your patience while we let the AFL and ASADA investigation take its course."


He said the Bombers could at least take heart that their players were showing maturity and character in adversity.


"These young men are utter professionals in what they are doing week in and week out," he said.





  





No comments:

Post a Comment